Knowing which cancer tumours have their own microbiomes could lead to more personalised treatments.
Articles on Cancer
Displaying 21 - 40 of 1114 articles
An oncologist answers the key questions about the new sitting-and-cancer study, and what its findings do and don’t show.
Lung cancer screening promises to find cancer early and treat it before it progresses. But a year on, issues have emerged.
A new national research agenda, shaped by patients, caregivers and clinicians, will guide the future of adolescent and young adult cancer research in Canada.
When celebrities go public with their prostate cancer diagnoses, they do more than raise awareness.
Too many Australians affected by cancer are being financially ruined or receiving sub-optimal (or no) care, due to cost or distance – and it’s everyone’s problem.
The goal is to develop treatments that can strip away the sugar shield cancer uses to hide from the immune system.
Consumers in Europe and Asia have used sunscreen containing bemotrizinol for decades, and many say its approval in the US is long overdue.
Jeremy Clarkson says his prostate cancer is ‘aggressive’. Here’s what that actually means.
The major drivers of liver cancer are largely preventable – yet public awareness of the disease remains low.
Cancer deaths in the US have dropped steeply since 1991. But the medical and public health advances leading to these declines have been concentrated among high-income areas.
CAR-T therapy engineers a patient’s own immune cells to fight cancer. Making these cels more resilient can make treatments more effective.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
The treatment is shorter and more convenient, but it will not suit every man with prostate cancer.
The risk to firefighters isn’t just from breathing wildfire smoke – it’s also in the chemicals that get on their clothes and filter through to their skin.
Scolyer captured the world’s attention when he volunteered for a world-first experimental treatment for brain cancer. He died on Sunday night, aged 59.
Researchers are investigating whether blood tests and heart scans can detect hidden heart damage during breast cancer chemotherapy.
Social media is spruiking the health benefits of ‘lymphatic draining’. 2 lymphoedema experts explain what it is and whether it works.
Kevin Keegan’s cancer diagnosis and a surprising statistical quirk. What car crashes, shark attacks and workplace safety have in common.
Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor, Department of Biomedical and Life Sciences, Lancaster University
-
Senior Lecturer in Cancer Biology & Clinical Biochemistry, Kingston University
-
Senior Lecturer in Genetics and Molecular Biology, Kingston University
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor, School of Medicine, University of Connecticut
-
Associate professor, University of Sydney
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Graduate Student in Cancer Systems Biology, Rice University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney